The Patent Finder

Proteosys AG

Also on record
Records under this name other than patents Proteosys AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Proteosys AG

PatentTitleStatus Expires Confidence
US 10,350,269Method of Effecting Neuroprotection Using Soluble Neuregulin Isoforms
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,813,978Method of Effecting Neuroprotection Using Soluble Neuregulin Isoforms
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 12,251,423Method of Effecting Neuroprotection Using Soluble Neuregulin Isoforms
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 7,824,923Neuregulin-β isoforms associated with neuronal processes
Formerly held
Term ended
Term ended Dec 16, 2022 · From the USPTO record
Term endedTerm ended Dec 16, 2022From the USPTO record
US 7,919,582Neuregulin-β isoform
Formerly held
Term ended
Ended no later than Feb 9, 2021 · From the USPTO record
Term endedEnded no later than Feb 9, 2021From the USPTO record
US 8,466,144Muscarinic antagonists with parp and sir modulating activity as cytoprotective agents
Lapsed on the fee record
Ended Jun 18, 2017 · From the USPTO record
Lapsed on the fee recordEnded Jun 18, 2017From the USPTO record
US 7,538,197Use of neuregulin-β as an indicator and/or target
Formerly held
Lapsed on the fee record
Ended May 26, 2017 · From the USPTO record
Lapsed on the fee recordEnded May 26, 2017From the USPTO record
US 8,409,812Annexin A3 for Cancer Diagnosis
Lapsed on the fee record
Ended Apr 2, 2017 · High confidence
Lapsed on the fee recordEnded Apr 2, 2017High confidence
US 8,377,648Autoimmune regulation of prostate cancer by annexin A3
Lapsed on the fee record
Ended Feb 19, 2017 · From the USPTO record
Lapsed on the fee recordEnded Feb 19, 2017From the USPTO record
US 8,039,464Muscarinic antagonists with PARP and SIR modulating activity as agents for inflammatory diseases
Lapsed on the fee record
Ended Oct 18, 2015 · From the USPTO record
Lapsed on the fee recordEnded Oct 18, 2015From the USPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited